Table 2

 Reasons for termination of the study (counts (%))

Azithromycin (n = 81)Placebo (n = 71)
No or insufficient response treatment5 (6)4 (6)
Laboratory abnormalities1 (1)1 (1)
Adverse events3 (4)2 (3)
Patient’s request3 (4)3 (4)
Investigator’s decision6 (7)11 (15)
Intra-articular corticosteroid injections1 (4)1 (1
Other4 (5)1 (1)
Completed study57 (70)47 (66)